Evaluation of TAOK2 as a novel therapeutic target for personalized treatment of triple negative and HER2 breast cancers

Project: Research

Project Details

Project Description

NBCF application
StatusActive
Effective start/end date1/11/1930/12/21

Funding

  • National Breast Cancer Foundation: AUD508,876.03